1. Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1. (December 2022) Authors: Huang, Min; O'Shaughnessy, Joyce; Haiderali, Amin; Pan, Wilbur; Hu, Peter; Chaudhuri, Mitashri; Le Bailly De Tilleghem, Celine; Cappoen, Nicolas; Fasching, Peter A. Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Survival outcomes and treatment costs for patients with double‐refractory chronic lymphocytic leukaemia (DR‐CLL). (20th November 2014) Authors: Bloor, Adrian; De Cock, Erwin; Hatswell, Anthony J; Wasiak, Radek; Elvidge, Jamie; Stapelkamp, Ceilidh; Hadjivassileva, Tsveta; Haiderali, Amin; Delgado, Julio Journal: British journal of haematology Issue: Volume 169:Number 3(2015:May) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices. (25th September 2018) Authors: Whitman, Eric D; Liu, Frank Xiaoqing; Cao, Xiting; Diede, Scott J; Haiderali, Amin; Abernethy, Amy P Journal: Future oncology Issue: Volume 15:Number 5(2019) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗